• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
82,057.68 2,603.21
( 3.28%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,266.30 -123.15
(-0.30%)
Dow Jones
5,680.75 -4.19
(-0.07%)
Hang Seng
37,650.80 147.47
(0.39%)
Nikkei 225
8,554.80 23.19
(0.27%)
Forex
USD-INR
85.39 0.69
(0.81%)
EUR-INR
96.28 0.21
(0.22%)
GBP-INR
113.48 0.52
(0.46%)
JPY-INR
0.59 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
95.9811761
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
0
39619.8
EPS(TTM)
Face Value()
Div & Yield %
0.41
5
0.38
 

Biocon consolidated net profit rises 154.24% in the March 2025 quarter
May 09,2025
Net profit of Biocon rose 154.24% to Rs 344.50 crore in the quarter ended March 2025 as against Rs 135.50 crore during the previous quarter ended March 2024. Sales rose 12.79% to Rs 4358.10 crore in the quarter ended March 2025 as against Rs 3863.80 crore during the previous quarter ended March 2024.

For the full year,net profit declined 0.90% to Rs 1013.30 crore in the year ended March 2025 as against Rs 1022.50 crore during the previous year ended March 2024. Sales rose 6.03% to Rs 15052.20 crore in the year ended March 2025 as against Rs 14195.80 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales4358.103863.80 13 15052.2014195.80 6
OPM %24.7423.63 -21.0422.64 -
PBDT902.70734.80 23 3477.103105.60 12
PBT466.40327.80 42 1790.101536.80 16
NP344.50135.50 154 1013.301022.50 -1